CDK9-IN-12
CDK9-IN-12 is a potent and selective CDK9 inhibitor used in leukemia research. It suppresses oncogenic transcription, leading to proliferation arrest and apoptosis in cancer cells, as demonstrated in various in vitro and in vivo preclinical studies.
Product Specifications
CAS Number
1942843-54-0
Product Name Alternative
CDK9IN12, CDK-9-IN-12, CDK9-IN-12, CDK9 IN 12
Field of Research
Cell Biology, Epigenetics & Chromatin
Purity
98.93% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (8.71 mM) ; DMSO:80 mg/mL (211.16 mM)
Smiles
ClC1=C (C=2C=C3C (=CC2) NN=C3C) C=C (N[C@@H] (CO) C4=CC=CC=C4) C=N1
Molecular Formula
C21H19ClN4O
Molecular Weight
378.86
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS9441409-01 0.1 mL (Biotin)
STAT5A/STAT5B Polyclonal Conjugated Antibody
Sign In for Pricing
View Details MBS9441409-02 0.1 mL (AF350)
STAT5A/STAT5B Polyclonal Conjugated Antibody
Sign In for Pricing
View Details 
MBS9441409-03 0.1 mL (AF405)
STAT5A/STAT5B Polyclonal Conjugated Antibody
Sign In for Pricing
View Details MBS9441409-04 0.1 mL (AF488)
STAT5A/STAT5B Polyclonal Conjugated Antibody
Sign In for Pricing
View Details 
MBS9441409-05 0.1 mL (AF555)
STAT5A/STAT5B Polyclonal Conjugated Antibody
Sign In for Pricing
View Details MBS9441409-06 0.1 mL (AF594)
STAT5A/STAT5B Polyclonal Conjugated Antibody
Sign In for Pricing
View Details